Phillips-Medisize’s increased business to benefit Molex plant in Arkansas

This article was originally published here

Phillips-MedisizePhillips-Medisize today announced a doubling of production for an undisclosed fast-growing medical customer with a take-home diagnostic kit for cancer detection – with benefits for the plant that Phillips-Medisize’s parent Molex runs in Little Rock, Ark.

Phillips-Medisize, which is based in Hudson, Wis., did not disclose the identity of the customer, which it described as a leader in consumable diagnostics cancer testing.

The company in the past, though, has touted work it has done for Madison, Wis.–based Exact Sciences (Nasdaq: EXAS), maker of the take-home Cologuard colon cancer test. Cologuard test volume more than doubled to 571,000 tests in 2017.

Get the full story on our sister site Medical Design & Outsourcing. 

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply